A pharmacist-driven Food and Drug Administration incident surveillance and response program for compounded drugs.

Autor: Janusziewicz AN; Office of Compounding Quality and Compliance, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD,USA., Glueck SN; Office of Compounding Quality and Compliance, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD,USA., Park SY; Office of Compounding Quality and Compliance, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD,USA., Nguyen DN; Office of Compounding Quality and Compliance, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD,USA., Rimmel SC; Office of Compounding Quality and Compliance, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD,USA., Cascio LA; Office of Compounding Quality and Compliance, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD,USA., Doh GY; Office of Compounding Quality and Compliance, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD,USA., Martin-Yeboah GF; Office of Compounding Quality and Compliance, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD,USA.

Publikováno v: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2021 Jul 22; Vol. 78 (15), pp. 1438-1443.